Sex difference in the safety and efficacy of bariatric procedures: a systematic review and meta-analysis.

Biliopancreatic diversion Bioenteric intragastric balloon Complications Laparoscopic adjustable gastric banding Metabolic surgery Roux-en-Y gastric bypass Safety Sex Sleeve gastrectomy Weight loss

Journal

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
ISSN: 1878-7533
Titre abrégé: Surg Obes Relat Dis
Pays: United States
ID NLM: 101233161

Informations de publication

Date de publication:
07 2022
Historique:
received: 23 02 2021
revised: 23 02 2022
accepted: 19 03 2022
pubmed: 7 6 2022
medline: 29 6 2022
entrez: 6 6 2022
Statut: ppublish

Résumé

With the prevalence of obesity alarmingly increasing, it is of primary interest to identify those factors predicting the success of anti-obesity therapeutic strategies currently adopted in clinical practice, and in particular, those of bariatric procedures showing the greatest success in terms of weight loss and maintenance in both the short and long term. Given sex-related differences in psychosocial status, hormonal homeostasis, and body fat distribution, it is likely that the response to different weight management strategies differs by sex. The objective was to elucidate the effect of sex on different bariatric procedures' efficacy and safety outcomes. Searches of PubMed, Cochrane, and Embase databases were performed, followed by hand-searching of reference lists from all relevant articles. We included all the studies evaluating the effect of bariatric procedures on body mass index loss (BMIL), and/or percentage excess weight loss (%EWL), and/or percentage excess body mass index loss, and/or percentage of responders, and/or short-/long-term complications and co-morbidity resolution, broken down by sex. Twenty-seven studies with a total of 114,919 patients were included. Men were more likely to achieve greater BMIL, consistent with higher male baseline BMI, and women were 2.87 times more likely to be classified as weight responders (95% confidence interval [CI]: 1.90-4.34), as well as to perform better in terms of %EWL (95% CI: .13-.54). Upon subgroup analysis based on bariatric procedure, women were more likely to be successful in terms of %EWL upon bioenteric intragastric balloon (BIB) placement (.72, 95% CI: .42-1.02). There was no sex difference regarding investigated co-morbidity resolution (hypertension, diabetes, and obstructive sleep apnea syndrome) or occurrence of short-term complications, whereas women were more likely to develop long-term complications, with an odds ratio of 1.97 (95% CI: 1.57-2.49). Sex does not have a clear effect on efficacy outcomes of bariatric procedures. Differentiating by procedure, BIB may be more effective in women, although results are discordant based on the weight loss outcome considered. If the short-term postoperative complication rate is similar across both sexes, long-term complications occur more frequently in women. To clarify the real effect of sex on bariatric procedure-derived health benefits, it is crucial to report sex-stratified results in future studies, as well as evaluate body composition changes that go beyond simple body weight reduction.

Identifiants

pubmed: 35668018
pii: S1550-7289(22)00149-6
doi: 10.1016/j.soard.2022.03.022
pii:
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

983-996

Informations de copyright

Copyright © 2022 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Renata Risi (R)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.

Giovanni Rossini (G)

Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy.

Rossella Tozzi (R)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.

Silvia Pieralice (S)

Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy.

Lavinia Monte (L)

Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy.

Davide Masi (D)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.

Lidia Castagneto-Gissey (L)

Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy.

Ida Francesca Gallo (IF)

Bariatric Surgery Unit, Campus Bio-Medico University of Rome, Rome, Italy.

Lidia Strigari (L)

Department of Medical Physics, Policlinico S. Orsola-Malpighi, Bologna, Italy.

Giovanni Casella (G)

Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy.

Vincenzo Bruni (V)

Bariatric Surgery Unit, Campus Bio-Medico University of Rome, Rome, Italy.

Silvia Manfrini (S)

Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy.

Lucio Gnessi (L)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.

Dario Tuccinardi (D)

Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy. Electronic address: d.tuccinardi@unicampus.it.

Mikiko Watanabe (M)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH